The charter calls on trial sponsors, regulators and ethics committees to offer support to those with communication or mobility problems that might hamper their participation. (newscientist.com)
The agency also asked that trial sponsors inform any patients who have received similar treatments of the adverse result. (discovermagazine.com)
The proposal also asks for input on whether trial sponsors should be required to submit their protocol to help the public understand the results. (sciencemag.org)